| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 744650 | Null | 0.0244718705444135 | 0.40967579 |
| NSC 746035 | 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone | 0.0244718705444135 | 0.29661737 |
| NSC 748903 | [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a,4a-diol] | 0.0244718705444135 | 0.0048306387 |
| NSC 752461 | Null | 0.0244718705444135 | 0.029987946 |
| NSC 755423 | Null | 0.0244718705444135 | -0.031391885 |
| NSC 756134 | GSK1023156A | 0.0244718705444135 | 0.0082833982 |
| NSC 9598 | 3-(Dimethylamino)-7-(methylimino)-3H-phenothiazine hydrochloride | 0.0244718705444135 | 0.15066743 |
| NSC 100290 | Doxypyrromycin hydrochloride | 0.0244718705444139 | 0.076955486 |
| NSC 116693 | Null | 0.0244718705444139 | 0.17336402 |
| NSC 133072 | Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) | 0.0244718705444139 | -1.4431732e-005 |